Institution
OLVG
Also known as: Onze Lieve Vrouwe Gasthuis
- 15running trials
- 6closed trials
- 7,828publications (OpenAlex)
Running trials
Not yet recruiting
Effectiveness and Safety of Uptitration of Guideline Directed MEdical Therapy in Heart Failure With Reduced Ejection Fraction With Limited Kidney Function Assessments
NCT07275437· University Medical Center Groningen· Source
Active, not recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433· Phase 3· Amgen· Source
Recruiting
OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes
NCT06476119· The Netherlands Cancer Institute· Source
Active, not recruiting
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
NCT06052059· Phase 3· Merck Sharp & Dohme LLC· Source
Active, not recruiting
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes
NCT06008756· Phase 3· Merck Sharp & Dohme LLC· Source
Active, not recruiting
Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)
NCT05817942· Alfasigma S.p.A.· Source
Active, not recruiting
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
NCT05197049· Phase 3· Janssen Research & Development, LLC· Source
Active, not recruiting
Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
NCT04959448· Regeneron Pharmaceuticals· Source
Active, not recruiting
Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)
NCT04608318· Phase 3· German CLL Study Group· Source
Enrolling by invitation
The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)
NCT06083155· Radboud University Medical Center· Source
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT04033445· Phase 2/3· Janssen Research & Development, LLC· Source
Active, not recruiting
A Post-market Clinical Follow up of the Genio® System for the Treatment of Obstructive Sleep Apnea in Adults
NCT04031040· Nyxoah S.A.· Source
Active, not recruiting
Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial
NCT01558921· Phase 3· University Medical Center Groningen· Source
Active, not recruiting
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
NCT00005584· Phase 3· European Organisation for Research and Treatment of Cancer - EORTC· Source
Active, not recruiting
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
NCT00002462· Phase 3· European Organisation for Research and Treatment of Cancer - EORTC· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Registry name variants (6)
Show allHide
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Onze Lieve Vrouwe Gasthuis
Amsterdam, 1091 HA
15 trials
Onze Lieve Vrouwe Gasthuis (OLVG)
Amsterdam
2 trials
5280016 - Onze Lieve Vrouwe Gasthuis
Amsterdam, 1091 AC
1 trial
Onze Lieve Vrouwe Gasthuis, locatie Oost
Amsterdam, 1091 AC
1 trial
Onze Lieve Vrouwe Gasthuis (Site 1405)
Amsterdam, North Holland 1051 AC
1 trial
Onze Lieve Vrouwe Gasthuis (Site 1922)
Amsterdam, North Holland 1051 AC
1 trial
Report an error